Immunoreactivity for A103, an antibody to Melan-A (Mart-1), in adrenocortical and other steroid tumors

American Journal of Surgical Pathology

Volumn 22, Issue 1, 1998, Pages 57-63

  Busam, K J ^a   Iversen, K ^b   Coplan, K A ^b   Old, L J ^b   Stockert, E ^b   Chen, Y T ^b,c   McGregor, D ^d   Jungbluth, A ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

Author keywords

Adrenocortical tumors; MART 1; Melan A; Melanocytes; Steroid tumors

Indexed keywords

MONOCLONAL ANTIBODY;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEYDIG CELL TUMOR; MALE; MELANOMA; OVARY CANCER; SERTOLI CELL TUMOR; TESTIS CANCER;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CROSS REACTIONS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEYDIG CELL TUMOR; MALE; MICE; NEOPLASM PROTEINS; SERTOLI-LEYDIG CELL TUMOR; UROGENITAL NEOPLASMS;

EID: 0031985748     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199801000-00007     Document Type: Article

References (40)

1. Argenyi ZB, Cain C, Bromley C, et al. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study. Am J Dermatopathol 1994;16:233-40.
2. Beaty MW, Fetsch P, Wilder AM, Matincola F, Abati A. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody. Cancer 1997;81:57-63.
3. Boel P, Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-75.
4. Brichard V, Van Pel A, Woelfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous sytolytic T lymphocytes. J Exp Med 1993;178:489-95.
5. Busam KJ, Barnhill RL. Special stains in the evaluation of melanocytic lesions. Melanoma Lett 1994;12:1-4.
6. Chen Y-T, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ, Old LJ. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogenously expressed in human melanomas. Proc Natl Acad Sci USA 1996;93:5915-4.
7. Chen Y-T, Stockert E, Tsang S, Coplan KA, Old LJ. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 1995;92:8125-8129.
8. Cote RJ, Cordon-Cardo C, Reuter VE, Rosen PP. Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Am J Pathol 1990;136:1077-84.
9. Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
10. Fetsch PA, Cromier J, Hijazi YM. Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas. J Immunother 1997;20:60-4.
11. Fetsch PA, Kleiner D, Marincola FM, Abati A. Analysis of melanoma-associated antigen, MART-1, in normal tissues and in selected non-melanomatous neoplasms. Abstract to the 86th annual meeting of the USCAP. Mod Pathol 1997;10:43.
12. Foucar E, Dehner LP. Renal cell carcinoma occurring with contralateral adrenal metastasis. A clinical and pathological trap. Arch Surg 1979;114:959-63.
13. Fuhrmann SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
14. Gaffey MJ, Traweek SJ, Mills SE, et al. Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical carcinoma, hepatocellular carcinoma, and renal cell carcinoma. Hum Pathol 1992;23:144-53.
15. Gaugler B, Van den Eynde B, Van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-30.
16. Huak HR, Fleuren GJ. Neuroendocrine differentiation of adrenocortical tumors. Cancer 1995;75:860-4.
17. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:6458-42.
18. Kawakami Y, Eliyahu S, Sakaguchi K, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994;180:347-52.
19. Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. A clincopathological analysis of 40 cases and a review of the literature. Am J Surg Pathol 1985;9:177-92.
20. Lack EE. Tumors of the adrenal gland and extra-adrenal paraganglia. Atlas of Tumor Pathology, 3rd ed. Vol. 19. Washington, DC: Armed Forces Institute of Pathology; 1997:123-68.
21. Marincola FM, Hijazi YM, Fetsch P, et al. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell tines and in in situ lesions. J Immunother 1996;19:192-205.
22. Medeiros LJ, Michie SA, Johnson DE, Warnke RA, Weiss LM. An immunoperoxidase study of renal cell carcinomas: correlation with nuclear grade, cell type, and histologic pattern. Hum Pathol 1988;19:980-7.
23. Miettinen M, Lehto V-P, Virtanen I. Immunofluorescence microscopic evaluation of the intermediate filament expression in the adrenal cortex and medulla and their tumors. Am J Pathol 1985;118:360-6.
24. Nakano M. Adrenal cortical carcinoma. A clinicopathological and immunohistochemical study of 91 autopsy cases. Acta Pathol Jpn 1988;38:163-80.
25. Page DL, DeLellis RA, Hough AJ. Tumors of the adrenal. Atlas of Tumor Pathology. 2nd ed. Vol. 23. Washington, DC: Armed Forces Institute of Pathology; 1986:115-49.
26. Ro JY, Sahin AA, Ayala AG. Tumors and tumorous conditions of the male genital tract. In: Fletcher CDM, ed. Diagnostic Histopathalogy of Tumors. Hong Kong: Churchill Livingston; 1995:521-99.
27. Robbins PF, El-Gamil M, Kawakami Y, Rosenberg SA. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994;54:3124-6.
28. Schroeder S, Niendorf A, Achilles E, et al. Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11. Virchows Arch 1990;417:89-96.
29. Schroeder S, Padberg BC, Achilles E, Holl K, Dralle H, Kloeppel G. Immunocytochemistry in adrenocortical tumors: a clinicopathological study of 72 neoplasms. Virchows Arch [A] 1992;420:65-70.
30. Sloane JP, Ormerod MG. Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer 1981;47:1786-95.
31. Silva EG, Mackay B, Samaan NA, Hickey RC. Adrenocortical carcinomas: an ultrastructural study of 22 cases. Ultrastruct Pathol 1982;3:1-7.
32. Springvall DR, Gu J, Cocchia D, et al. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. Virchows Arch [A] 1983;400:331-44.
33. Tartour E, Caillou B, Tenenbaum F, et al. Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody. Cancer 1993;72:3296-303.
34. Van den Eynde B, Peeters O, De Backer O, Gaugier B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995;182:689-98.
35. Van der Bruggen P, Traversari C, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
36. Wang RF, Robbing PF, Kawatauni Y, Kang X-Q, Rosenberg SA. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J Exp Med 1995;181:799-804.
37. Weiss LM. Comparative histoiogic study of 43 metastasizing and non-metastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-9.
38. Weiss LM, Medeiros LJ, Vickery AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-206.
39. Wick MR, Cherwitz DL, McGlennen RC, Dehner LP. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Am J Pathol 1986;122:343-52.
40. Young RH, Scully RE. Steroid cell tumors of the ovary: In: Lowe D, Fox E, eds. Advances in Gynaecological Pathology. Edinburgh, Scotland: Churchill Livingstone; 1992:277-98.